Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer
Clinical trial NCT01607892 · COMPLETED
Trial details
- NCT number
- NCT01607892
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-23
- Primary completion
- 2015-10-13
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.